JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB93596

Anti-AICDA antibody

Be the first to review this product! Submit a review

|

(3 Publications)

Rabbit Polyclonal AICDA antibody. Suitable for IHC-P and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human AICDA.

View Alternative Names

AID, AICDA, Single-stranded DNA cytosine deaminase, Activation-induced cytidine deaminase, Cytidine aminohydrolase

1 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AICDA antibody (AB93596)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AICDA antibody (AB93596)

Immunohistochemical staining of formalin-fixed paraffin-embedded lymph node showing cytoplasmic staining with ab93596 at 1/100 dilution.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

Synthetic Peptide within Human AICDA. The exact immunogen used to generate this antibody is proprietary information.

Q9GZX7

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/500", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
Affinity purified
Storage buffer
Preservative: 0.02% Sodium azide Constituents: 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

AICDA also known as activation-induced cytidine deaminase is an enzyme with a molecular mass of approximately 25 kDa. It is expressed in germinal center B cells within the lymphoid tissues particularly in the spleen and lymph nodes. AICDA catalyzes the deamination of cytidine to uridine in single-stranded DNA an essential step in the processes of somatic hypermutation and class switch recombination. These mechanisms are important for antibody diversity and specificity in the adaptive immune response.
Biological function summary

AICDA plays an important role in the adaptive immune system by facilitating the diversification of antibodies. It does not appear to function as part of a larger protein complex but operates independently to induce mutations in variable regions of immunoglobulin genes. This activity enables B cells to produce antibodies with higher affinity and different isotypes important for an effective immune defense system. AICDA’s function ensures the generation of diverse antibody repertoires allowing the immune system to effectively target a wide range of pathogens.

Pathways

AICDA is integral to the immunoglobulin gene diversification pathway. It initiates somatic hypermutation and class switch recombination by deaminating cytosine residues in the DNA of immunoglobulin genes. This action relates AICDA to other proteins involved in DNA repair and error-prone replication such as uracil-DNA glycosylase (UNG) and the mismatch repair proteins like MSH2 and MSH6. AICDA's deamination activity triggers the recruitment of these proteins to introduce mutations and remove uracil residues facilitating the generation of antibody diversity.

Aberrant AICDA activity associates with lymphomas and autoimmune conditions. For example dysregulation of AICDA could contribute to oncogenic mutations leading to non-Hodgkin's lymphoma. Additionally incorrect or unscheduled activation of AICDA might result in the production of autoantibodies implicated in autoimmune disorders like systemic lupus erythematosus (SLE). AICDA’s interaction with DNA repair proteins during misguided activation may lead to genomic instability linking it to both tumorigenesis and autoimmunity.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Single-stranded DNA-specific cytidine deaminase. Involved in somatic hypermutation (SHM), gene conversion, and class-switch recombination (CSR) in B-lymphocytes by deaminating C to U during transcription of Ig-variable (V) and Ig-switch (S) region DNA. Required for several crucial steps of B-cell terminal differentiation necessary for efficient antibody responses (PubMed : 18722174, PubMed : 21385873, PubMed : 21518874, PubMed : 27716525). May also play a role in the epigenetic regulation of gene expression by participating in DNA demethylation (PubMed : 21496894).
See full target information AICDA

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

iScience 26:108523 PubMed38162032

2023

AID-induced CXCL12 upregulation enhances castration-resistant prostate cancer cell metastasis by stabilizing β-catenin expression.

Applications

Unspecified application

Species

Unspecified reactive species

Qi Li,Jinfeng Fan,Zhiyan Zhou,Zhe Ma,Zhifei Che,Yaoxi Wu,Xiangli Yang,Peiyu Liang,Haoyong Li

Nature 587:472-476 PubMed33149302

2020

Gut-educated IgA plasma cells defend the meningeal venous sinuses.

Applications

Unspecified application

Species

Unspecified reactive species

Zachary Fitzpatrick,Gordon Frazer,Ashley Ferro,Simon Clare,Nicolas Bouladoux,John Ferdinand,Zewen Kelvin Tuong,Maria Luciana Negro-Demontel,Nitin Kumar,Ondrej Suchanek,Tamara Tajsic,Katherine Harcourt,Kirsten Scott,Rachel Bashford-Rogers,Adel Helmy,Daniel S Reich,Yasmine Belkaid,Trevor D Lawley,Dorian B McGavern,Menna R Clatworthy

Cancer biology & therapy 20:169-182 PubMed30183475

2018

Enhancing the efficacy of glycolytic blockade in cancer cells RAD51 inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

John J Wilson,Kin-Hoe Chow,Nathan J Labrie,Jane A Branca,Thomas J Sproule,Bryant R A Perkins,Elise E Wolf,Mauro Costa,Grace Stafford,Christine Rosales,Kevin D Mills,Derry C Roopenian,Muneer G Hasham
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com